Respiratory solutions to combat the effects of air pollution4 Jun 2018
Aptar Pharma to unveil inhalation drug delivery solutions at CPhI China 2018.
At CPhI China, Aptar Pharma will be introducing new market innovations in inhalation drug delivery for the Chinese market, demonstrating the benefits of these exciting respiratory solutions designed to combat the effects of air pollution.
They will also be showcasing their innovative Connected Device portfolio, which covers application fields such as Respiratory and Eye Care. Visitors will have the opportunity to discover these intuitive devices featuring fully connected functionality and software integration for improving patient health outcomes.
Another highlight of the booth will be Aptar Pharma’s drug delivery systems expertise in dermal innovation. Specialists will be on hand to discuss the newly enhanced dispensing solutions for Aptar Pharma’s Airless Dermal Drug Delivery Systems, providing insight into how their technologies and features can support pharmaceutical professionals’ drug formulations and consumer products.
In addition to exhibiting, Aptar Pharma will be hosting a half-day seminar on Friday morning, 22 June, featuring two Aptar pharma experts who will present the following interactive sessions:
A Q&A session will follow the seminar, which will take place at location N8 in Meeting Room D from 9.30am to noon.
Guenter Nadler of Aptar Pharma, comments: ‘We are delighted to once again participate in CPhI China, which connects us with the entire Chinese pharmaceutical market. We look forward to showcasing our new market innovations and demonstrating our expertise to industry leaders through our broad drug delivery solutions and our seminar presentations at this event’.
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation